Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

NEULAND LABORATORIES LTD.

NSE : NEULANDLABBSE : 524558ISIN CODE : INE794A01010Industry : Pharmaceuticals & DrugsHouse : Private

BSE14399.65-899.25 (-5.88 %)

PREV CLOSE ( ) 15298.90

OPEN PRICE ( ) 15001.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 20868

TODAY'S LOW / HIGH ( )14223.80 15001.00

52 WK LOW / HIGH ( )7900 18089.55

NSE14381.00-892 (-5.84 %)

PREV CLOSE( ) 15273.00

OPEN PRICE ( ) 15010.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 14381.00 (44)

VOLUME 206756

TODAY'S LOW / HIGH( ) 14155.00 15010.00

52 WK LOW / HIGH ( )7920.1 18100

Select year

(Rs.in Million)

Particulars

Mar 2025

Mar 2024

Mar 2023

Mar 2022

Mar 2021

Profit Before Tax

3463.29

4014.37

2157.46

821.63

1053.34

Adjustment

-120.05

620.76

779.28

663.04

400.85

Changes In working Capital

577.85

-907.32

-128.34

-675.85

492.17

Cash Flow after changes in Working Capital

3921.09

3727.80

2808.40

808.82

1946.35

Cash Flow from Operating Activities

3173.83

2611.77

2372.12

603.89

1893.62

Cash Flow from Investing Activities

-2981.56

-1496.87

-614.99

-955.16

-844.24

Cash Flow from Financing Activities

249.61

-692.82

-1357.96

377.22

-1136.60

Net Cash Inflow / Outflow

441.88

422.08

399.18

25.94

-87.22

Opening Cash & Cash Equivalents

875.75

454.16

50.91

24.36

112.04

Cash & Cash Equivalent on Amalgamation / Take over / Merger

Cash & Cash Equivalent of Subsidiaries under liquidations

Translation adjustment on reserves / op cash balalces frgn subsidiaries

Effect of Foreign Exchange Fluctuations

1.67

-0.49

4.07

0.62

-0.46

Closing Cash & Cash Equivalent

1319.30

875.75

454.16

50.91

24.36